Prenetics Global Limited, a health sciences company, has purchased $20 million worth of Bitcoin for its corporate treasury strategy.
The purchase includes 187.42 BTC at an average price of $106,712, with plans to allocate the majority of its $117 million balance sheet to Bitcoin.
The company transferred ownership of ACT Genomics to increase its cash reserves to approximately $66 million and total liquid assets to around $117 million.
CEO Danny Yeung stated the company now has a solid financial foundation for innovative treasury management approaches, including the Bitcoin strategy.
Former OKEx COO Andy Cheung has been appointed to the Board of Directors and will implement active treasury management strategies.
Prenetics plans to expand its BTC holdings through institutional partnerships and accept Bitcoin payments on its platforms, including IM8 Health and CircleDNA.
The company is working with industry advisors Tracy Hoyos Lopez and Raphael Strauch to guide its Bitcoin strategy.
Prenetics reported significant revenue growth in Q1 2025, with a 336.5% year-over-year increase.
The company aims to implement a long-term Bitcoin strategy for transformative value proposition.
Prenetics' move highlights Bitcoin's growth and potential integration within the healthcare sector.